AR061263A1 - METHOD TO TREAT RESPIRATORY DISORDERS - Google Patents

METHOD TO TREAT RESPIRATORY DISORDERS

Info

Publication number
AR061263A1
AR061263A1 ARP070102454A ARP070102454A AR061263A1 AR 061263 A1 AR061263 A1 AR 061263A1 AR P070102454 A ARP070102454 A AR P070102454A AR P070102454 A ARP070102454 A AR P070102454A AR 061263 A1 AR061263 A1 AR 061263A1
Authority
AR
Argentina
Prior art keywords
respiratory disorders
treat respiratory
antibiotic
antibiotic drug
aerosol composition
Prior art date
Application number
ARP070102454A
Other languages
Spanish (es)
Inventor
Hanumantharao Tatapudy
Syed M Shah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38657254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR061263(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR061263A1 publication Critical patent/AR061263A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un método para tratar trastornos respiratorios mediante el suministro de una composicion en aerosol de una droga antibiotica a los alvéolos pulmonares. La droga antibiotica comprende ZOSYN, piperacilina, Tazobactam o TYGACIL y es administrada por vía de un sistema SWIRLER que produce una composicion en aerosol líquida de la droga antibiotica en la cual el tamano de las gotas de antibiotico en el aerosol rondan de 1 a 3 micrometros o menos.A method of treating respiratory disorders by supplying an aerosol composition of an antibiotic drug to the pulmonary alveoli. The antibiotic drug comprises ZOSYN, piperacillin, Tazobactam or TYGACIL and is administered via a SWIRLER system that produces a liquid aerosol composition of the antibiotic drug in which the size of the antibiotic drops in the aerosol is about 1 to 3 micrometers. or less.

ARP070102454A 2006-06-07 2007-06-07 METHOD TO TREAT RESPIRATORY DISORDERS AR061263A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81167106P 2006-06-07 2006-06-07

Publications (1)

Publication Number Publication Date
AR061263A1 true AR061263A1 (en) 2008-08-13

Family

ID=38657254

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102454A AR061263A1 (en) 2006-06-07 2007-06-07 METHOD TO TREAT RESPIRATORY DISORDERS

Country Status (4)

Country Link
AR (1) AR061263A1 (en)
PE (1) PE20080712A1 (en)
TW (1) TW200815003A (en)
WO (1) WO2007145866A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641249A (en) * 2012-05-06 2012-08-22 江苏奥赛康药业股份有限公司 Preparation method of tigecycline composition
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
MX2020004205A (en) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions.
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
US9566399B1 (en) 2015-04-14 2017-02-14 Clempharma LLC Deep lung alveolar aerosol targeted drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5603314A (en) * 1995-03-22 1997-02-18 Bono; Michael Aerosol filtration device and inhalation apparatus containing same
WO2003075890A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. Methods for entrapment of bioactive agent in a liposome or lipid complex

Also Published As

Publication number Publication date
WO2007145866A1 (en) 2007-12-21
PE20080712A1 (en) 2008-05-22
TW200815003A (en) 2008-04-01

Similar Documents

Publication Publication Date Title
AR061263A1 (en) METHOD TO TREAT RESPIRATORY DISORDERS
HRP20201325T1 (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
AR109590A2 (en) POSTOLOGICAL REGIME FOR COMT INHIBITORS
AR044007A1 (en) METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
CO7190240A2 (en) System to treat lung infections
CL2007002356A1 (en) PHARMACEUTICAL LIBERATION SYSTEM THAT INCLUDES FLIBANSERINE AND AT LEAST AN ACCEPTABLE PHARMACEUTICALLY EXCIPIENT; AND ITS USE FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEMS, AFFECTIVE, SOUND AND SEXUAL DISORDERS, AMONG OTHERS.
AR113749A1 (en) SYNTHETIC AND PLANT-BASED CANNABINOID FORMULATIONS WITH QUICK-ONSET AND LONG-ACTING
CL2008001966A1 (en) Oral dissolution composition comprising lamotrigine, in the form of lamotrigine particles coated with a taste-masking layer and granules comprising a disinfectant and a sugar alcohol and / or a carbohydrate; method of preparation, use to treat mood disorders and prevention of attacks.
CO6280475A2 (en) METHOD TO TREAT THE DEFICIENCY OF VITAMIN B12
AR059359A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING PLECONARIL
ECSP099556A (en) NEW METHODS
BR112015022465A2 (en) Non-toxic treatment method for drug withdrawal syndrome
CO6400190A2 (en) TREATMENT OF COGNITIVE DISORDERS WITH (R) -7-CHLORINE-N- (QUINUCLIDIN-3-IL) BENZO [B] THIOPHEN-2-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME
AR061262A1 (en) METHOD FOR TREATMENT OF RESPIRATORY DISORDERS USE OF AN ANTIBIOTIC IN THE MANUFACTURE OF AN AEROSOL AND COMPOSITION OF ANTIBIOTIC IN AEROSOL
AR045312A1 (en) METHOD THAT UNDERSTANDS THE NASAL ADMINISTRATION OF XILITOL TO A NON-HUMAN MAMMER
BR112014008602A2 (en) pharmaceutical composition, sealed container, metered dose inhaler, methods for treating a patient suffering or likely to suffer from a respiratory disorder, and method for manufacturing a pharmaceutical composition
AR091205A1 (en) PHARMACO TO PREVENT AND TREAT POLIQUISTIC RENAL DISEASE
AR050903A1 (en) METHOD FOR THE PREVENTION OF THROMBOTIC, EMBOLIC AND / OR HEMORRAGICAL DISORDERS
DOP2003000585A (en) NICOTINAMIDE DERIVATIVES AND A COMBINATION TIOTROPIO SALT FOR THE TREATMENT OF DISEASES
BR112019005318A2 (en) aza-indazole compounds for use in tendon and / or ligament injuries
CL2016001707A1 (en) Treatment of cognitive disorders with (r) -7-chloro-n- (quinuclidin-3-yl) benzo (b) thiophene-2-carboxamide and pharmaceutically acceptable salts thereof (div. Sol. 1178-11).
UY31662A1 (en) COMPOSITIONS OF RANITIDINE TABLETS OF ORAL DISINTEGRATION AND ITS METHODS OF ELABORATION.
CL2009000322A1 (en) Pharmaceutical composition comprising flibanserin in its amorphous form and at least one excipient, pharmaceutical delivery system comprising this composition, method for manufacturing this system and its use for the treatment of central nervous system disorders, affective disorders, sleep and sexual disorders , among others.
AR092104A1 (en) LAQUINIMOD IN THE TREATMENT OF DISORDERS MEDIATED BY THE G-AMINOBUTIRIC ACID (GABA)
BR112019005578A2 (en) indazole compounds for use in tendon and / or ligament injuries

Legal Events

Date Code Title Description
FB Suspension of granting procedure